Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

Journal of Clinical Investigation

Volumn 107, Issue 9, 2001, Pages 1117-1126

  Herman, Michael P ^a   Sukhova, Galina K ^a   Kisiel, Walter ^b   Foster, Don ^c   Kehry, Marilyn R ^d,e   Libby, Peter ^a   Schönbeck, Uwe ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c ZYMOGENETICS INC   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLACENTA PROTEIN 5; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MONONUCLEAR PHAGOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER;

EID: 0035023342     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10403     Document Type: Article

References (54)

1. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor
2. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor
3. Purification and characterization of placental protein 5
4. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2
5. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor
6. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis
7. Collagen polymorphism in the normal and diseased blood vessel wall. Investigation of collagens types I, III and V
8. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life
9. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
10. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
11. Matrix metalloproteinases
12. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: A role for CD40 signaling in plaque rupture?
13. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
14. Activation of human monocytes through CD40 induces matrix metalloproteinases
15. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages
16. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion
17. Activation mechanisms of matrix metalloproteinases
18. Mechanisms for pro matrix metalloproteinase activation
19. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
20. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases
21. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family
22. Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and TIMP4 genes to human chromosome 3p25 and mouse chromosome 6, respectively
23. Mechanism of inhibition of the human matrix metalloproteinase stromelysin- 1 by TIMP- 1
24. Tissue inhibirors of metalloproteinases: Evolution, structure and function
25. The tissue metalloproteinase family and the inhibitor TIMP: A study using cDNAs and recombinant proteins
26. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity
27. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: A potential protective mechanism in plaque stability
28. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
29. Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts
30. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage
31. The cell biology of leukocyte-mediated proteolysis
32. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor
33. The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases
34. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium
35. Regulation of matrix metalloproreinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
36. HT- 1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI
37. High-affinity interactions of rumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization
38. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease
39. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium
40. Matrix metalloproteinases in tumour invasion and metastasis
41. Matrix matters
42. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
43. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability
44. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells
45. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate
46. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
47. Molecular bases of the acute coronary syndromes
48. The smooth muscle cell: Sinner or saint in restenosis and the acute coronary syndromes?
49. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture
50. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments
51. Native type I collagen is not a subsrtrate for MMP2 (gelatinase A)
52. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
53. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis
54. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture